All In MedTech

Device Trial Radar · NCT07685834

Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss

Pilot Observational Evaluation of Facial and Neck Skin Laxity With SofWave Treatment in Adults Initiating Tirzepatide for Weight Loss

Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

30

Planned (sponsor's estimate)

Start

Feb 27, 2026

Primary completion

Mar 1, 2027

Study completion Mar 1, 2027

Sponsor

Lead sponsor
Sofwave Medical LTDNot on our public-company list
Sponsor type
Industry
First posted
Jul 6, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated device
No
Who can join
Female only, from 30 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Open-label, randomized double-arm prospective, single-center, self-controlled clinical study.

Conditions

  • Lax Skin

Interventions

  • SUPERBDevice

    The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues. Pure Impact is an EMS module. This module is wirelessly connected to and controlled by the SofWave console. It functions independently from the existing ultrasound module. Pure Impact generates electrical impulses, which are delivered through electrodes on the skin in direct proximity to the muscles to be stimulated.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Improvement in the appearance of lax skinTime frame: 20 WEEKS POST LAST TREATMENT

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Dr.Jean Carruthers Cosmetic Surgery

    Vancouver, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.